Abstract 5017: Targeting human melanoma growth with non-calcemic vitamin d3 hydroxyderivative: A synergistic approach with vemurafenib
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: University of Alabama at Birmingham, Oregon State University
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148668088
Cites:
Cited by:
Related to: